We are looking forward to seeing you at NeurIPS 2024 in Vancouver. Come and talk to us about our open ML Research Engineer roles at Isomorphic Labs. Our hiring managers will be attending. Register your interest here: bit.ly/40Vo4tR #ai #drugdiscovery #NeurIPS2024
Isomorphic Labs
Biotechnology Research
We are reimagining the entire drug discovery process from first principles with an AI-first approach.
About us
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.
- Website
-
https://www.isomorphiclabs.com/
External link for Isomorphic Labs
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Get directions
London, GB
Employees at Isomorphic Labs
Updates
-
How is AI saving billions of years of human research time? Our Chief AI Officer Max Jaderberg just released a TED talk describing a powerful new paradigm: Our ability to develop AI analogues of the ‘real messy world’ of biology, recreating it with neural network architectures that fuel open-ended scientific discovery to ultimately design new ways to modulate biology. bit.ly/3Z6YyiU Watch to learn more about: ➡️ How AI solved the 50-year protein folding problem with AlphaFold and how we anticipate other breakthroughs of equal magnitude in our life-time ➡️ AI Analogues could reverse the curse of Eroom’s law ➡️ How could we use AI to modulate the function of proteins in cancer to stop this protein’s DNA repairing, leaving just healthy cells remaining ➡️ How AlphaFold 3 diffuses the coordinates of atoms in our biomolecular system giving us a completely malleable virtual biomolecular world ➡️ Instead of having one chemist working on developing new therapeutic designs, we have thousands of agents, guided and nurtured by the human ingenuity of our human chemist instead #AI #DrugDesign #TEDAI
Max Jaderberg: How AI is saving billions of years of human research time
https://www.ted.com
-
Don't miss this insightful story on the future of AI in Fast Company, featuring Demis Hassabis, CEO of Isomorphic Labs and Google DeepMind. Harry McCracken also spent time with Isomorphic Labs President Colin Murdoch to learn about how we are advancing drug design with AI. Read it here: https://lnkd.in/eAkGJJCF
-
Calling ML Engineers, come and join our team at Isomorphic Labs. We are offering the opportunity to meet our hiring managers to kick off the recruitment process at NeurIPS 2024 Joanna Yoo, Marco Fiscato, Oliver Osborne Learn more here: bit.ly/40Vo4tR #ai #drugdiscovery #NeurIPS2024
-
-
Isomorphic Labs reposted this
Next gen alphafold, future generative models, holy-grail models for drug design, and agents for actual science. I’m looking for builders to join our incredibly talented ML scientists and engineers at Isomorphic Labs to create the future of drug design
Research Scientist, Machine Learning, London
job-boards.greenhouse.io
-
Our CSO Miles Congreve is speaking on a panel alongside Max Vasquez, chaired by Jane Osbourn OBE on how AI is transforming biotech at SV Health Investors Forum 2024. Join the conversation at 2.00 pm in London, on Monday 18th November. Register here to join the webinar: bit.ly/48LE6Zn
-
-
‘AlphaFold is just one small piece of the puzzle of drug discovery at Isomorphic. You also need other systems that can do chemical synthesis design, predict ADME properties, and all the other things you need. We plan to fill out that entire stack, eventually maybe putting them all end-to-end . . .’ At the Financial Times Global Pharma and Biotech Summit in London, our CEO Demis Hassabis sat down with Andrew Dunn to delve into our work at Isomorphic Labs and how artificial intelligence continues to drive advancements in science. Find out more: https://lnkd.in/e4YKKgsD
Q&A: Demis Hassabis talks winning the Nobel Prize, building an AI biotech sans lab, and Trump’s potential impact
endpts.com
-
Isomorphic Labs reposted this
"#AlphaFold has saved a Billion years of research time." Max Jaderberg reveals how AI is revolutionizing drug discovery, accelerating breakthroughs that were once thought impossible, all powered by AlphaFold’s cutting-edge capabilities at #TEDAI. As Chief AI Officer at Isomorphic Labs, Max leads the charge in applying machine learning to redefine drug discovery. With #AI now at the forefront of biomedical research, Jaderberg’s work is helping to bring new cures to the world at unprecedented speed. #DrugDiscovery
-
-
Isomorphic Labs Chief AI Officer Max Jaderberg will join Carlo Rovelli, Surya Ganguli and Steven Johnson on the Science and Creativity panel at #TEDAI on the 23rd of October to discuss how we are using AI to drive a new wave of innovation in digital biology that holds the potential to transform human health and shape the future of medicine. 👉 If you’re at the event, come and join the discussion: bit.ly/3NrxJ3u
What is the promise of new discoveries for scientists and creators? Explore the transformative potential of Generative AI for the future of scientific discoveries and creativity in this engaging panel. Panelists will share insights on how GenAI is reshaping innovation across disciplines, from accelerating scientific breakthroughs to empowering new forms of artistic expression. 🌌 Carlo Rovelli, world-renowned theoretical physicist and bestselling author, will take you on a journey through the mysteries of space, time, and quantum theory. His pioneering work on loop quantum gravity and philosophical musings on science will reshape how you perceive the universe. 🧠 Surya Ganguli, professor at Stanford and venture partner at a16z, explores the intricate connections between biological and artificial neural networks. With his groundbreaking research spanning neuroscience, physics, and AI, Surya is revolutionizing our understanding of both human cognition and machine learning. 💊 Max Jaderberg, Chief AI Officer at Isomorphic Labs, is at the forefront of AI-powered drug discovery. His work is accelerating biomedical breakthroughs, transforming healthcare through digital biology, and driving innovation in AI applications that hold the potential to change lives. 🎨 Steven Johnson, acclaimed author of Where Good Ideas Come From and How We Got to Now, will explore the intersection of history, creativity, and innovation. Steven’s insights into how scientific ideas and creative moments collide will offer a unique perspective on the dynamics of discovery and invention. 🎟 Join them at TED AI San Francisco to discover the promise GenAI holds for both scientists and creators alike. https://lnkd.in/eU9Z8Xxu #TEDAI #ScienceAndCreativity #AIInnovation #FutureOfScience #QuantumPhysics
-
-
Our Chief Technology Officer Sergei Yakneen delivered the keynote speech at TechBio 2024, sharing his insights on the potential for AI to transform the drug design process and the progress being made at Isomorphic Labs.
Here to deliver the final #keynote is Sergei Yakneen, Chief Technology Officer, Isomorphic Labs. Isomorphic Labs' CEO Demis Hassabis recently received The Nobel Prize in 🧪 #Chemistry for his work on developing #AlphaFold, a groundbreaking #AI system that predicts the 3D structure of proteins from their amino acid sequences ⚗️ 🎉 #Congratulations to the team on this monumental award 👏 #TechBio #TechBioUK #Biotech
-